Gapping up
In reaction to strong earnings/guidance:
- TWLO +17.1%, SEND +16.7%, XOG +14.7%, ETSY +13.2%, CUTR +12.9%, ODP +10.9%, FIVN +10.5%, DIOD +10.4%, WTTR +10%, CSLT +7.9%, ITG +7.9%, NEWR +7%, CPE +6.5%, PLNT +6.3%, RCKT +5.8%, VIRT +5.5%, CCLP +5.4%, GHDX +5.2%, MEET +5.1%, MNTA +4.6%, VSI +4.6%, LC +4.4%, RPD +4.4%, HALO +4.4%, PXD +4.4%, FTK +4.3%, PUMP +4.1%, VGR +4.1%, AAXN +4%, PZZA +3.6%, DATA +3.6%, HZNP +3.4%, XEC +3.2%, BTG +2.7%, PAGP +2.4%, FTI +2.4%, PAA +2.3%, BGNE +2.3%, CCS +2.2%, GGB +1.8%, GRPN +1.8%, AG +1.6%, SBGI +1.4%, PSEC +1%, .
M&A news:
- ARRS +17.7% (CNBC reporting Arris is near a deal to be acquired by CommScope [COMM] for more than $31/share)
- DVMT +3.9% (WSJ reporting potential for improved Dell offer)
- KHC +1% (Kraft Heinz to sell Canadian natural cheese business to Parmalat for purchase price of CAD$1.62 bln)
Other news:
- RENN +19.3% (CM Seven Star Acquisition Corp [CMSS] enters into business combination with Renren's [RENN] Kaixin Auto Group)
- SRCI +18.5% (Colorado voters reject Proposition 112 measure)
- FOMX +15% (announces its Phase 3 Studies FX2016-11 and FX2016-12 met both co-primary endpoints)
- GNC +12.2% (reaches agreement w/ Harbin Pharma for the funding of Hayao's investment, enters into JV Framework Agreement with respect to joint ventures in Hong Kong and China)
- FMS +9.3% (California voters reject Proposition 8)
- AVEO +5.9% (after closing the day 20% lower)
- RCKT +5.8% (announces the clearance of the Company's INDapplication for RP-L102, the Company's lentiviral vector (LVV)-based gene therapy for the treatment of Fanconi Anemia by the FDA)
- BR +2.6% (modestly rebounding -- clarifies guidance from call - narrows Q2 estimated revs range)
- MDR +1.5% (company confirms Chairman, CEO, CFO share purchases)
Analyst comments:
- PTI +6% (initiated with Overweight rating and $21 tgt at Cantor Fitzgerald)
- WES +5.3% (upgraded to Buy from Neutral at BofA/Merrill)
- ONCE +2.6% (upgraded to Neutral from Underperform at Wedbush)
![]()